Home 2018-07-18T12:14:50+00:00


At M4K Pharma, we are using open science to revolutionize how affordable new treatments are discovered and developed. Through our Medicines4Kids program, we will aggregate and align the work of global academics, foundations and industry researchers to advance new cures for childhood diseases not well-served by current business models.

M4K Pharma’s Data:
In line with M4K Pharma’s open science principles, we are committed to sharing our research data freely in the public domain. Our data is currently available for public viewing in the video recordings of our monthly open scientific updates, which are posted to our Blog and also available through our YouTube Channel. Data will be openly available in a downloadable format soon.

DIPG stole yet another beautiful child. 😔 Our condolences to the Nicholas family. Thank you ❤️Aubreigh❤️ for spreading awareness about DIPG with the #lemonfacechallenge. We will continue to work hard to find a cure for this horrible disease. https://t.co/8pj6zhwSkW

Ros Adamson @thesgconline provides updates on protein constructs used to enable the structure-based optimization of ALK2 inhibitors. #Openscience notebook record: https://t.co/5xX08AyndG Accompanying blog: https://t.co/Za8UVOiLpY

REMINDER tomorrow is our open Scientific Update Meeting. Join us and be a part of open source drug discovery to #defeatDIPG !! Everyone is welcome! Wednesday August 15th (10:00am-12:00pm EST) on Zoom at:
https://t.co/eIejGEztwZ #OpenScience

An OICR-funded team of researchers, led by Dr. Aled Edwards from M4K Pharma, have developed new potential drug candidates for DIPG that they will test in animal models in the coming months https://t.co/KK5jJTh6S9 @OICR_news @M4KPharma @thesgconline #DIPG #BrainCancer


Grad students. Want to see how drug discovery projects are run from the “inside”? It’s a secret no more! Join the monthly chemistry team meetings! #opendrugdiscovery https://t.co/SThlJ1GbQA

Load More...

Latest Blog Posts